People hate drug ads on TV. Here’s the 4 issues they complain about most
By Kate Sheridan
Molly Ferguson for STAT
In the U.S., pharmaceutical advertising seems inescapable, yet most people would rather not see these ads at all. We looked at the complaints people have lodged with the FCC about prescription drug ads. Most focused on one of four issues.
The multifaceted role of the nonclinical expert at the center of drug development teams
Regulatory authorities mandate product development teams include a nonclinical expert to ensure safety issues are addressed consistently throughout the development lifecycle. With highly-diverse training and experience, nonclinical experts can help guide the team toward better-informed decisions on regulatory and safety matters, in addition to creating an environment that facilitates collaboration and trust. Allucent outlines the importance and benefits of putting a nonclinical expert at the heart of your team. Explore further.
No comments